EUVIMEDEUVIMED entdecken
Open Access · CC0

Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination

Anthony L Guerrerio iD, Allyson Mateja, Gretchen MacCarrick, Jonathan Fintzi, Erica Brittain, Pamela A Frischmeyer-Guerrerio, Harry C Dietz

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0315499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Anthony L Guerrerio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, U…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Connective Tissue Diseases, COVID-19, COVID-19 Vaccines. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCI NIH HHS, National Cancer Institute, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 infection and vaccination have been reported to confer an elevated risk for cardiovascular events (CVE). We sought to determine whether individuals with an underlying vascular connective tissue disorder including Marfan syndrome (MFS), Loeys-Dietz syndrome (LDS), or vascular Ehlers Danlos syndrome (vEDS) are at increased risk for cardiac events after COVID-19 infection or vaccination.

Methods

325 respondents self-reported data through a cross-sectional, web-based survey available from 22 November 2021, through 15 March 2022 regarding COVID-19 illness and vaccinations, the occurrence of any CVE, and adverse events following vaccination. The data were analyzed using a Cox proportional hazards model with time varying indicators for COVID-19 illness/vaccination in the preceding 30 days.

Results

COVID-19 illness was significantly associated with an increased rate of a new abnormal heart rhythm 30 days following infection. No other CVEs were reported in the 90 days after COVID-19 illness. We did not find evidence of an increased rate of any CVE in the 30 days following any COVID-19 vaccination dose.

Conclusion

In respondents with MFS, LDS, or vEDS, we uncovered no evidence of an increase in CVEs in the 30 days following COVID-19 illness, with the possible exception of dysrhythmia. In light of the absence of a substantial increase in self-reported CVEs in the 30 days following COVID-19 vaccination, these data are in keeping with the recommendation from the Marfan Foundation Professional Advisory Board that all eligible persons be vaccinated for COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesConnective Tissue DiseasesCOVID-19COVID-19 VaccinesVaccinationAdultAgedFemaleHumansMaleMiddle AgedCross-Sectional StudiesLoeys-Dietz SyndromeMarfan Syndrome

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research. Frederick, Maryland, United States of America.
  • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • The Laboratory of Allergic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.

ORCID-Profile: Anthony L Guerrerio

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • Howard Hughes Medical Institute
  • Loeys-Dietz Syndrome Foundation
  • William S. Smilow Center for Marfan Syndrome Research
  • Kasper Precision Medicine Center of Excellence for Genetic Syndromes and Aortopathies
  • Johns Hopkins in Health strategic initiative

Zitieren

APA

Guerrerio, A. L., Mateja, A., MacCarrick, G., Fintzi, J., Brittain, E., Frischmeyer-Guerrerio, P. A., & Dietz, H. C. (2024). Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination. PLOS ONE. https://doi.org/10.1371/journal.pone.0315499

Vancouver

Guerrerio AL, Mateja A, MacCarrick G, Fintzi J, Brittain E, Frischmeyer-Guerrerio PA, et al. Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination. PLOS ONE. 2024. doi:10.1371/journal.pone.0315499

BibTeX
@article{Guerrerio2024,
  author = {Guerrerio, Anthony L and Mateja, Allyson and MacCarrick, Gretchen and Fintzi, Jonathan and Brittain, Erica and Frischmeyer-Guerrerio, Pamela A and Dietz, Harry C},
  title = {Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0315499}
}
Kostenlos starten →